Andreas Behren
Melbourne Austin Branch
Melbourne, VIC, Australia
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
Characterisation of tumor-infiltrating gamma-delta T cells in human colorectal cancer with MHC-I loss.
Journal: Clinical & translational immunology
Published: November 04, 2025
Common inherited loss-of-function mutations in the innate sensor NOD2 contribute to exceptional immune response to cancer immunotherapy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 07, 2025
Differentiation grade is highly concordant between matched primary and metastatic colorectal cancer.
Differentiation grade is highly concordant between matched primary and metastatic colorectal cancer.
Journal: Clinical & experimental metastasis
Published: July 05, 2025
A TAK1 cytokine toxicity checkpoint controls anti-cancer immunity.
Journal: Cell reports
Published: May 22, 2025
Lung cancer biobanking in Australia: challenges and future directions.
Journal: The Medical journal of Australia
Published: January 16, 2025
Case report: Partial regression of metastatic squamous cell carcinoma with altered azathioprine dosage after long-term use in renal transplant patient.
Journal: Frontiers in immunology
Published: August 02, 2024
Circulating immune cells exhibit distinct traits linked to metastatic burden in breast cancer.
Journal: Breast cancer research : BCR
Published: June 23, 2024
T cell factor 1 (TCF-1) defines T cell differentiation in colorectal cancer.
Journal: iScience
Published: December 27, 2023
TCF-1 limits intraepithelial lymphocyte antitumor immunity in colorectal carcinoma.
Journal: Science immunology
Published: October 06, 2023
Vγ9Vδ2 T cells recognize butyrophilin 2A1 and 3A1 heteromers.
Journal: Nature immunology
Published: September 13, 2023
PRMT1 acts as a suppressor of MHC-I and anti-tumor immunity.
Journal: Cell reports
Published: September 08, 2023
Durable response to combination immunotherapy using nivolumab and ipilimumab in metastatic succinate dehydrogenase (SDH)-deficient gastrointestinal stroma tumour.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 15, 2023
Last Updated: 09/26/2026